I absolutely agree.
Why weren't they compared to other children who were in similar situations. I'm guessing the population is quite small and variable as it's quite rare but no mention of the standard disease progression.
Would they have died? Where that assumption from? People are making assumptions left right and centre and making investment decisions based on them.
I'm merely pointing out these assumptions aren't valid.
The clinical results may be impressive. Maybe they're not. Again, who knows man.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
MSB
mesoblast limited
Add to My Watchlist
7.47%
!
$2.23

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-96
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.23 |
Change
-0.180(7.47%) |
Mkt cap ! $2.841B |
Open | High | Low | Value | Volume |
$2.33 | $2.35 | $2.15 | $13.51M | 5.995M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 20998 | $2.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.24 | 13380 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 38400 | 2.210 |
5 | 15867 | 2.200 |
7 | 19249 | 2.190 |
7 | 41524 | 2.180 |
5 | 31839 | 2.170 |
Price($) | Vol. | No. |
---|---|---|
2.220 | 26834 | 12 |
2.230 | 17686 | 12 |
2.240 | 59253 | 12 |
2.250 | 91243 | 12 |
2.260 | 50324 | 5 |
Last trade - 11.05am 21/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |